Skip to main content
Adeel Jamil, MD, Internal Medicine, Peoria, IL

AdeelJamilMDMRCP

Internal Medicine Peoria, IL

Hospital Medicine/Hospitalist

Attending Physician/ Internal Medicine

Dr. Jamil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jamil's full profile

Already have an account?

  • Office

    530 NE Glen Oak Ave
    Peoria, IL 61637
    Phone+1 309-624-8818
    Fax+1 309-683-4377

Education & Training

  • University of Alabama at Birmingham School of Public Health
    University of Alabama at Birmingham School of Public HealthMSPH, Outcomes Research, 2020 - 2023
  • Icahn School of Medicine at Mount Sinai (Bronx)
    Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2015 - 2018
  • Khyber Medical College
    Khyber Medical CollegeClass of 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2018 - 2026
  • Member Royal College of PhysicianMRCP (UK)

Publications & Presentations

PubMed

Journal Articles

  • Dual Antithrombotic Plus Adjunctive Antiinflammatory Therapy to Improve Cardiovascular Outcome in Atrial Fibrillation Patients with Concurrent Acute Coronary Syndrome:...  
    Gerald Chi, Adeel Jamil, Miroslav Radulovic, Umer Jamil, Muhammad A. Balouch, Jolanta Marszalek, Zahra Karimi, Seyedmahdi Pahlavani, Mehrian Jafarizade, Husnain Shauka..., Medical Hypotheses: DOI: https://doi.org/10.1016/j.mehy.2018.02.036, 3/2018
  • High-Density Lipoprotein-Targeted Therapy for Coronary Heart Disease: is the HDL Hypothesis Operational or Defunct?  
    Gerald Chi, Zahra Karimi, Farima Kahe, Seyedmahdi Pahlavani, Adeel Jamil and Arzu Kalayci, Current Trends in Biomedical Engineering & Biosciences (CTBEB), 2/16/2018
  • Inflammation and Atherothrombosis: The Beginning of the End of a Hypothesis  
    Adeel Jamil, Umer Jamil, Sunny Kumar, Muhammad Akrmah, Ghaffarpasand, Gerald Chi, EC Cardiology, 1/5/2018
  • Join now to see all

Abstracts/Posters

  • Comparative Efficacy and Safety of Rivaroxaban-Based Dual-Pathway Antithrombotic Therapy Versus Dual Antiplatelet Therapy: a Pooled Analysis of Contemporary Randomized...
    Adeel Jamil, Umer Jamil, Michela Faggioni, Jolanta Marszalek, Sara Mehrsefat, Seyedmahdi Pahlavani, Usama Talib, Zahra Karimi, Miroslav Radulovic, Gerald Chi, J Am Coll Cardiol. 2018 Mar;71(11_S):38. doi: 10.1016/S0735-1097(18)30579-5, ACC 2018, 3/10/2018

Professional Memberships

Other Languages

  • Urdu, Hindi, Punjabi